Mode
Text Size
Log in / Sign up
N/A N=45 Randomized Single-blind Treatment

CBT Enhanced With Social Cognitive Training

Depression

Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcome: Primary: Faux Pas Recognition Test — 0.901; 0.854 score on a scale — p=< 0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive behavior therapy with social cognitive training (CBT+SCT) (Behavioral); CBT-only (Behavioral)
Age
Pediatric · 12+ yrs
Sex
All
Sponsor
Vanderbilt University
Primary completion
Aug 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Faux Pas Recognition Test
0.901; 0.854 < 0.05 sig
SECONDARY
Children Depression Rating Scale - Revised
23.74; 34.59 < 0.05 sig

Summary

Depression in youth is a serious public health concern for which more personalized treatments are needed. This study will test the effect of an intervention aimed at enhancing depressed children's social cognitive capacities (e.g., ability to take another's perspective), thereby making treatment of depression in youth more efficient and effective. Participants in both the R61 (N=42) and R33 (N=82) will be youth between 12 and 17 years old currently experiencing a depressive disorder. Youth will be randomized to either an enhanced CBT intervention that teaches social cognitive skills, particularly social perspective taking and theory of mind as compared to CBT only. The primary target is improvement in the social cognitive skills at post treatment in the first trial (R61) and improvements in both social cognitive skills and depressive symptoms at post-treatment and at a 4-month follow-up (R33).

Eligibility Criteria

Inclusion Criteria

  • 12- to 17-years-old
  • diagnosis of a current depressive disorder (e.g., major depressive episode; persistent depressive disorder) or a score on the Children's Depression Rating Scale (CDRS) >= 40

Exclusion Criteria

  • ever met criteria for a diagnosis of bipolar disorder, schizophrenia, autism, or conduct disorder
  • current alcohol or substance use disorder with significant impairment
  • imminent risk of suicide
  • reading level < 4th grade
  • estimated IQ<80
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03954392). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search